Evidence map›Paper›PMID 35257042›Full record

ArticleJACC. Basic to translational science2022

H

Kohsuke Shirakawa, Eiji Kobayashi, Genki Ichihara, Hiroki Kitakata, Yoshinori Katsumata, Kazuhisa Sugai, Yoji Hakamata, Motoaki Sano

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2025
    Review
  7. Article
  8. Unraveling NETs in Sepsis: From Cellular Mechanisms to Clinical Relevance.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kohsuke ShirakawaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Eiji KobayashiCenter for Molecular Hydrogen Medicine, Keio University, Tokyo, Japan.
Genki IchiharaDepartment of Cardiology, School of Medicine, Keio University, Tokyo, Japan.
Hiroki KitakataDepartment of Cardiology, School of Medicine, Keio University, Tokyo, Japan.
Yoshinori KatsumataCenter for Molecular Hydrogen Medicine, Keio University, Tokyo, Japan.
Kazuhisa SugaiDepartment of Basic Sciences, Faculty of Veterinary Sciences, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, Japan.
Yoji HakamataDepartment of Basic Sciences, Faculty of Veterinary Sciences, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, Japan.
Motoaki SanoCenter for Molecular Hydrogen Medicine, Keio University, Tokyo, Japan.
Keio University · JPNippon Veterinary and Life Science University · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) contribute to inflammatory pathogenesis in numerous conditions, including infectious and cardiovascular diseases, and have attracted attention as potential therapeutic targets. H

Indexed as

BAL, bronchoalveolar lavageCitH3, citrullinated histone H3CVD, cardiovascular diseasedsDNA, double-stranded DNAH2HOCl, hypochlorous acidLPS, lipopolysaccharideMI, myocardial infarctionMPO, myeloperoxidaseNAC, N-acetyl-L-cysteineNET, neutrophil extracellular trapneutrophil extracellular trapsPADI4, peptidyl arginine deiminase 4PA, pulmonary arteryphorbol-12-myristate-13-acetatePMA, phorbol-12-myristate-13-acetateROS, reactive oxygen species

Identifiers

PMID35257042
PMCPMC8897170
OpenAlexW4205183538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.